https://www.selleckchem.com/products/rrx-001.html
The metabolic demands associated with critical illness place patients at risk for nutritional deficits. Carnitine is a small molecule essential for fatty acid oxidation and gluconeogenesis. Secondary carnitine deficiency can have clinically significant complications and has been observed anecdotally in patients receiving ECMO therapy at our institution. Guidelines for monitoring and supplementing carnitine are lacking. This retrospective study determined whether critically ill pediatric patients on ECMO have an increased risk of carniti
Like
Comment
Share
